BRPI0815455A2 - composição e uso de um composto - Google Patents

composição e uso de um composto

Info

Publication number: BRPI0815455A2
Authority: BR; Brazil
Prior art keywords: compound; composition
Prior art date: 2007-09-06

Application number

BRPI0815455A

Other languages

English (en)

Inventor

Aubert Jérôme

Dumais Laurence

Lamy Laurent

Portal Thibaud

Original Assignee

Galderma Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-06

Filing date

2008-09-05

Publication date

2017-06-27

2008-09-05 Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev

2017-06-27 Publication of BRPI0815455A2 publication Critical patent/BRPI0815455A2/pt

2018-02-06 Publication of BRPI0815455A8 publication Critical patent/BRPI0815455A8/pt

2020-11-10 Publication of BRPI0815455B1 publication Critical patent/BRPI0815455B1/pt

2020-12-01 Publication of BRPI0815455B8 publication Critical patent/BRPI0815455B8/pt

2021-05-25 Publication of BRPI0815455C1 publication Critical patent/BRPI0815455C1/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Birds (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Hematology (AREA)
Ophthalmology & Optometry (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

BRPI0815455A 2007-09-06 2008-09-05 compostos derivados de n-fenilacetamida, composição farmacêutica, composição cosmética, uso cosmético de uma composição, e usos de um composto do mesmo BRPI0815455C1 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
FR0757394		2007-09-06
FR0757394A FR2920774B1 (fr)	2007-09-06	2007-09-06	Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant
US60/960,067		2007-09-13
US96009707P	2007-09-14	2007-09-14
PCT/EP2008/061773 WO2009030747A1 (en)	2007-09-06	2008-09-05	Derivatives of n-phenylacetamide, inhibitors of the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them

Publications (5)

Publication Number	Publication Date
BRPI0815455A2 true BRPI0815455A2 (pt)	2017-06-27
BRPI0815455A8 BRPI0815455A8 (pt)	2018-02-06
BRPI0815455B1 BRPI0815455B1 (pt)	2020-11-10
BRPI0815455B8 BRPI0815455B8 (pt)	2020-12-01
BRPI0815455C1 BRPI0815455C1 (pt)	2021-05-25

Family

ID=39363894

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0815455A BRPI0815455C1 (pt)	2007-09-06	2008-09-05	compostos derivados de n-fenilacetamida, composição farmacêutica, composição cosmética, uso cosmético de uma composição, e usos de um composto do mesmo

Country Status (9)

Country	Link
US (1)	US8044082B2 (pt)
EP (1)	EP2197850B1 (pt)
JP (1)	JP2010538045A (pt)
AR (1)	AR068373A1 (pt)
BR (1)	BRPI0815455C1 (pt)
CA (1)	CA2698299A1 (pt)
ES (1)	ES2424659T3 (pt)
FR (1)	FR2920774B1 (pt)
WO (1)	WO2009030747A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2946345B1 (fr) *	2009-06-05	2011-05-20	Galderma Res & Dev	Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946346B1 (fr) *	2009-06-05	2011-05-20	Galderma Res & Dev	Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946342B1 (fr) *	2009-06-05	2011-06-24	Galderma Res & Dev	Nouveaux derives de dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946340B1 (fr) *	2009-06-05	2011-06-24	Galderma Res & Dev	Nouveaux n-phenyl acetamie, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946341B1 (fr) *	2009-06-05	2011-06-24	Galderma Res & Dev	Nouveaux derives de n-phenyl acetamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
EP2567959B1 (en)	2011-09-12	2014-04-16	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CN104902892A (zh) *	2012-02-02	2015-09-09	悉尼大学	泪液膜稳定性的改进

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH08151364A (ja) *	1994-02-18	1996-06-11	Nissan Chem Ind Ltd	含窒素環状化合物および除草剤
HUP0002294A3 (en) *	1997-05-26	2001-10-29	Kowa Co	Cyclic diamine compounds and medicines containing the same
EP1431294A4 (en) *	2001-08-22	2004-09-15	Kowa Co	ACAT INHIBITOR WITH SELECTIVITY FOR VESSEL WALLS
JP4333939B2 (ja)	2001-08-27	2009-09-16	ロード・コーポレーション	トロリ線の吊架装置
CA2557162A1 (en) *	2004-03-02	2005-09-09	Takeda Pharmaceutical Company Limited	Coumarin derivative and use thereof
US7409865B2 (en) *	2005-09-30	2008-08-12	General Electric Company	Diaphragm structure
AR057579A1 (es) *	2005-11-23	2007-12-05	Merck & Co Inc	Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
JP2007176809A (ja) *	2005-12-27	2007-07-12	Hideaki Natsukari	複素環置換アミド化合物、その製造法および医薬組成物
KR100662615B1 (ko) *	2006-01-13	2007-01-02	삼성전자주식회사	신호 변환 장치, 이를 구비한 ｒｆｉｄ 태그 및 ｒｆｉｄ태그의 구동 방법
US7612212B2 (en) *	2006-02-22	2009-11-03	Hoffmann-La Roche Inc.	Substituted hydantoins
WO2009086303A2 (en) *	2007-12-21	2009-07-09	University Of Rochester	Method for altering the lifespan of eukaryotic organisms

2007
- 2007-09-06 FR FR0757394A patent/FR2920774B1/fr not_active Expired - Fee Related
2008
- 2008-09-05 BR BRPI0815455A patent/BRPI0815455C1/pt not_active IP Right Cessation
- 2008-09-05 JP JP2010523511A patent/JP2010538045A/ja active Pending
- 2008-09-05 AR ARP080103869A patent/AR068373A1/es unknown
- 2008-09-05 ES ES08803742T patent/ES2424659T3/es active Active
- 2008-09-05 CA CA2698299A patent/CA2698299A1/en not_active Abandoned
- 2008-09-05 WO PCT/EP2008/061773 patent/WO2009030747A1/en not_active Ceased
- 2008-09-05 EP EP08803742.9A patent/EP2197850B1/en not_active Not-in-force
2010
- 2010-03-05 US US12/718,239 patent/US8044082B2/en active Active

Also Published As

Publication number	Publication date
US20100247583A1 (en)	2010-09-30
WO2009030747A1 (en)	2009-03-12
JP2010538045A (ja)	2010-12-09
US8044082B2 (en)	2011-10-25
BRPI0815455B1 (pt)	2020-11-10
EP2197850A1 (en)	2010-06-23
EP2197850B1 (en)	2013-06-26
CA2698299A1 (en)	2009-03-12
ES2424659T3 (es)	2013-10-07
AR068373A1 (es)	2009-11-11
FR2920774A1 (fr)	2009-03-13
FR2920774B1 (fr)	2009-10-30
BRPI0815455C1 (pt)	2021-05-25
BRPI0815455B8 (pt)	2020-12-01
BRPI0815455A8 (pt)	2018-02-06

Legal Events

Date	Code	Title	Description
2018-03-06	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2020-02-18	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-03-03	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2020-06-16	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2020-09-24	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-11-10	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/11/2020, OBSERVADAS AS CONDICOES LEGAIS.
2020-12-01	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: REF. RPI 2601 DE 10/11/2020 QUANTO A PRIORIDADE UNIONISTA.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/09/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2023-06-27	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 15A ANUIDADE.
2023-10-17	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2738 DE 27-06-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0906186A2 (pt)	2015-09-22	composto e uso de um composto
BRPI0810696A2 (pt)	2014-10-21	Composto, composição farmacêutica, e, uso de um composto
BRPI0919942A2 (pt)	2014-12-23	Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt)	2017-05-23	composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt)	2015-12-29	composto, composição farmacêutica, e, uso de um composto
BRPI0821165A2 (pt)	2015-06-16	Uso de uma composição
BRPI0921879A2 (pt)	2018-10-16	composto, composição farmacêutica , e, uso de um composto
BRPI0813770A2 (pt)	2014-12-30	Composição, e, uso de uma composição
BRPI0917579A2 (pt)	2016-10-11	composto, composição farmacêutica, métodos, e, uso de um composto
BRPI0915134A2 (pt)	2016-02-16	composto, e, uso de um composto
BRPI0810161A2 (pt)	2014-12-30	Composto, preparação farmacêutica, composição farmacêutica, e, uso de um composto
BRPI1016219A2 (pt)	2016-04-26	composto, composição farmacêutica, e, uso de um composto
BRPI1008793A2 (pt)	2016-03-08	composto, uso de um composto, e, composição farmacêutica
BRPI0908792A2 (pt)	2015-07-21	Composição, e, uso de uma combinação
BRPI0716327A2 (pt)	2014-03-04	Composto de fenilpropionamida e uso
BRPI0812942A2 (pt)	2014-12-16	Composto, composição farmacêutica e uso de um composto
BRPI0810019A2 (pt)	2014-10-14	Composto, composição farmacêutica, e, uso de um composto
BRPI1012533A2 (pt)	2015-09-22	composto de piradazinona e uso do mesmo
BR112012015392A2 (pt)	2017-04-25	"composto e uso cosmético de um composto"
BRPI0814304A2 (pt)	2015-02-03	Uso de um composto metálico misto
BRPI0819696A2 (pt)	2015-06-16	Compostos de derivados de 2-fenil-pirimidina, composição farmacêutica e uso de um composto
BRPI0906937A2 (pt)	2016-04-19	composto, composição farmacêutica, e, uso de um composto
BRPI0716698A2 (pt)	2014-02-25	Composto, composição farmacêutica e uso de um composto
BRPI0813627A2 (pt)	2014-12-23	Peptídio antimicrobiano, composições e métodos de uso
CR20130360A (es)	2013-09-03	Compuesto heterocíclico y su uso